Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor
Clinical trial NCT06083129 · RECRUITING
Trial details
- NCT number
- NCT06083129
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-28
- Primary completion
- 2028-11-28
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.